Journal of The Academy of Clinical Microbiologists

Register      Login

VOLUME 17 , ISSUE 1 ( January-June, 2015 ) > List of Articles

CASE REPORT

Rothia mucilaginosa pneumonia in an elderly patient from a tertiary care centre in Kerala

Tharekkad Gopalakrishanan Ramya, Sabitha Baby, Rithiyur K. Geetha

Keywords : Matrix-assisted laser desorption ionisation time-of-flight mass spectrometry, pneumonia, Rothia mucilaginosa

Citation Information : Ramya TG, Baby S, Geetha RK. Rothia mucilaginosa pneumonia in an elderly patient from a tertiary care centre in Kerala. 2015; 17 (1):43-44.

DOI: 10.4103/0972-1282.158808

License: CC BY-NC-SA 4.0

Published Online: 15-07-2024

Copyright Statement:  Copyright © 2015; Wolters Kluwer India Pvt. Ltd.


Abstract

Rothia mucilaginosa (previously Stomatococcus mucilaginosus) is a Gram-positive coccus residing in the oral cavity and respiratory tract as a part of normal flora. In the recent years, it has been associated with opportunistic infections in immunocompromised patients. In this case report, we present a case of pneumonia due to R. mucilaginosa. The isolate was confirmed using matrix-assisted laser desorption ionisation time-of-flight mass spectrometry system.


PDF Share
  1. Cho EJ, Sung H, Park SJ, Kim MN, Lee SO. Rothia mucilaginosa pneumonia diagnosed by quantitative cultures and intracellular organisms of bronchoalveolar lavage in a lymphoma patient. Ann Lab Med 2013;33:145-9.
  2. Becker K, Von Eiff C. Staphylococcus, Micrococcus and other catalase positive cocci. In: Becker K, Von Eiff C, Bernard KA, Carroll KC, Versalovic J, editors. Manual of Clinical Microbiology. 10th ed. Washington, DC: American Society for Microbiology; 2011. p. 308-30.
  3. Ruoff KL. Miscellaneous catalase-negative, gram-positive cocci: Emerging opportunists. J Clin Microbiol 2002;40:1129-33.
  4. Faiad G, Singh M, Narsimhan A, Mendez M, Shama S, Nassar N. Rothia mucilaginosa life threatening infections in nonneutropenic hosts. Open J Intern Med 2011;1:68-71
  5. Ascher DP, Zbick C, White C, Fischer GW. Infections due to Stomatococcus mucilaginosus: 10 cases and review. Rev Infect Dis 1991;13:1048-52.
  6. Treviño M, García-Zabarte A, Quintás A, Varela E, López-Paz JM, Jato A, et al. Stomatococcus mucilaginosus septicemia in a patient with acute lymphoblastic leukaemia. Eur J Clin Microbiol Infect Dis 1998;17:505-7.
  7. Cunniffe JG, Mallia C, Alcock PA. Stomatococcus mucilaginosus lower respiratory tract infection in a patient with AIDS. J Infect 1994;29:327-30.
  8. Korsholm TL, Haahr V, Prag J. Eight cases of lower respiratory tract infection caused by Stomatococcus mucilaginosus. Scand J Infect Dis 2007;39:913-7.
  9. von Eiff C, Herrmann M, Peters G. Antimicrobial susceptibilities of Stomatococcus mucilaginosus and of Micrococcus spp. Antimicrob Agents Chemother 1995;39:268-70.
  10. Kaiser AB, McGee ZA. Aminoglycoside therapy of gram-negative bacillary meningitis. N Engl J Med 1975;293:1215-20.
  11. Capitano B, Mattoes HM, Shore E, O'Brien A, Braman S, Sutherland C, et al. Steady-state intrapulmonary concentrations of moxifloxacin, Levofloxacin, and Azithromycin in older adults. Chest 2004;125:965-73.
  12. Zhanel GG, Ennis K, Vercaigne L, Walkty A, Gin AS, Embil J, et al. A critical review of the fluoroquinolones: Focus on respiratory infections. Drugs 2002;62:13-59.
  13. Lambotte O, Debord T, Soler C, Roué R. Pneumonia due to Stomatococcus mucilaginosus in an AIDS patient: Case report and literature review. Clin Microbiol Infect 1999;5:112-114.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.